Exelon

Links shared publicly online about this topic

Sun Pharma Announces Launch Of Generic Exelon(R) In US

medicalnewstoday.com — “Sun Pharma announced launch of generic Exelon®, rivastigmine tartrate capsules for the US market. Earlier, USFDA had granted final approval for the Company's ANDA to market these products.View full resource at medicalnewstoday.com

  • View Related
  • Share

Most Recently Shared on July 7, 2010 at 1:07 pm By:

mnt_parkinsons MNT Parkinson's News Health News

Sun Pharma Announces Launch Of Generic Exelon(R) In US http://mnt.to/3FMX #parkinsons

2 years ago...

Exelon Says Its 17 Reactors Are Safe - NYTimes.com

nytimes.com — “Exelon, the largest operator of nuclear plants in the United States, says it can handle emergencies not anticipated when the reactors were designed.View full resource at nytimes.com

  • View Related
  • Share

Most Recently Shared on March 25, 2011 at 5:23 am By:

nytimesscience NYTimes Science Science Enthusiast

Exelon, Largest U.S. Reactor Owner, Seeks to Reassure http://nyti.ms/gmplnH

11 months ago...

Verizon, Exelon to Record Health-Care Charge - WSJ.com

online.wsj.com — “Verizon is expected to take a one-time hit of $970 million to account for new overhaulView full resource at online.wsj.com

  • View Related
  • Share

Most Recently Shared on April 2, 2010 at 4:05 am By:

Novartis files suit against Watson over generic Exelon

news-medical.net — “Watson Pharmaceuticals, Inc. today confirmed that its subsidiary, Watson Laboratories, Inc., filed an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration (FDA) seeking approval to market rivastigmine transdermal system patches, 4.6 mg/24 hr and 9.5 mg/24 hr.View full resource at news-medical.net

  • View Related
  • Share

Most Recently Shared on November 11, 2011 at 5:17 am By:

Parkinsons_News News-Medical.Net Health News

Parkinson's Disease: Novartis files suit against Watson over generic Exelon: Watson Pharmaceuticals, Inc. today ... http://t.co/ldd6pUdi

3 months ago...

Potential Exelon Reactor in Texas Draws Foes - NYTimes.com

nytimes.com — “Citing problems with the chosen site, a Texas group objects to Exelon--™s plan to build a reactor sometime in the future.View full resource at nytimes.com

  • View Related
  • Share

Most Recently Shared on December 25, 2010 at 3:14 am By:

nytimesscience NYTimes Science Science Enthusiast

Early Bid for a Reactor Site Draws Opposition in Texas http://nyti.ms/hnESvl

1 year ago...

Exelon Corp. To Buy Constellation Energy For 7.9 Billion Dollars | ThirdAge

thirdage.com — “Exelon Corp., the U.S. energy giant, said Thursday it had agreed to merge with Constellation Energy in a $7.9 billion deal.View full resource at thirdage.com

  • View Related
  • Share

Most Recently Shared on April 28, 2011 at 10:00 pm By:

thirdagetimes ThirdAge.com Health Site

Exelon Corp. To Buy Constellation Energy For 7.9 Billion Dollars http://bit.ly/lA5j3l

9 months ago...

Exelon | Drug safety information | Monitoring more than 280 patients | MediGuard

mediguard.org — “Exelon | Drug safety information | Monitoring more than 280 patients | MediGuardView full resource at mediguard.org

  • View Related
  • Share

Most Recently Shared on March 21, 2011 at 12:17 pm By:

MediGuard MediGuard.org Health Organization

Over 110856888 #exelon users sharing experiences on MediGuard.org: http://tinyurl.com/6kp6x7c

11 months ago...

Sandoz launches rivastigmine tartrate capsules, authorized generic version of Exelon capsules - FiercePharma

fiercepharma.com — “Sandoz launches rivastigmine tartrate capsules, authorized generic version of Exelon® capsules Princeton, New Jersey; July 1, 2010 -- Sandoz today announced the introduction of rivastigmine... Read more...View full resource at fiercepharma.com

  • View Related
  • Share

Most Recently Shared on July 1, 2010 at 7:46 pm By:

FiercePharma FiercePharma Health Site

Sandoz launches rivastigmine tartrate capsules, authorized generic version of Exelon® capsules. http://bit.ly/aux2sj

2 years ago...

Anti-Delirium Drug May Harm Critically Ill Patients - Drugs.com MedNews

drugs.com — “The anti-delirium drug rivastigmine (brand name Exelon) does not appear to control delirium in critically ill hospital patients, new Dutch research indicates. WView full resource at drugs.com

  • View Related
  • Share

Most Recently Shared on November 5, 2010 at 12:05 am By:

Drugs_Devices Drugs and Devices OW OW Health

Anti-Delirium Drug May Harm Critically Ill Patients: THURSDAY, Nov. 4 -- The anti-delirium drug rivastigmi... http://bit.ly/bvPjQH #drug

1 year ago...

Anti-Delirium Drug May Harm Critically Ill Patients - Drugs.com MedNews

drugs.com — “The anti-delirium drug rivastigmine (brand name Exelon) does not appear to control delirium in critically ill hospital patients, new Dutch research indicates. WView full resource at drugs.com

  • View Related
  • Share

Most Recently Shared on November 5, 2010 at 3:17 am By:

drugscom Drugs.com Health Site

Anti-Delirium Drug May Harm Critically Ill Patients - http://bit.ly/9lnPiq

1 year ago...

Effect of rivastigmine as an adjunct to usual care with haloperidol on duration of delirium and mortality in critically ill patients: a multicentre, double-blind, placebo-controlled randomised trial : The Lancet

thelancet.com — “Effect of rivastigmine as an adjunct to usual care with haloperidol on duration of delirium and mortality in critically ill patients: a multicentre, double-blind, placebo-controlled randomised tria...View full resource at thelancet.com

  • View Related
  • Share

Most Recently Shared on November 10, 2010 at 7:29 pm By:

palmd PalMD Physician, Doctor, and Internist

Study of Exelon in hosp. delirium stopped due to excess mortality http://bit.ly/adSLBf http://www.thelancet.com/

1 year ago...

Anti-Delirium Drug May Harm Critically Ill Patients

health.yahoo.net — “THURSDAY, Nov. 4 (HealthDay News) -- The anti-delirium drug rivastigmine (brand name Exelon) does not appear to control delirium in critically ill hospital patients, new Dutch research indicates.View full resource at health.yahoo.net

  • View Related
  • Share

Most Recently Shared on November 5, 2010 at 11:29 am By:

nutritionbuff Jane Anderson Healthy Eating Advisor

Anti-Delirium Drug May Harm Critically Ill Patients http://bit.ly/9fQFd5

1 year ago...

Anti-Delirium Drug May Harm Critically Ill Patients

health.yahoo.net — “THURSDAY, Nov. 4 (HealthDay News) -- The anti-delirium drug rivastigmine (brand name Exelon) does not appear to control delirium in critically ill hospital patients, new Dutch research indicates.View full resource at health.yahoo.net

  • View Related
  • Share

Most Recently Shared on November 5, 2010 at 11:39 am By:

JennyBizRN Jennifer Ann Grisso Nurse and Active Health Library

Anti-Delirium Drug May Harm Critically Ill Patients: THURSDAY, Nov. 4 (HealthDay News) -- The anti-delirium drug... http://bit.ly/93LD10

1 year ago...

Anti-Delirium Drug May Harm Critically Ill Patients

health.yahoo.net — “THURSDAY, Nov. 4 (HealthDay News) -- The anti-delirium drug rivastigmine (brand name Exelon) does not appear to control delirium in critically ill hospital patients, new Dutch research indicates.View full resource at health.yahoo.net

  • View Related
  • Share

Most Recently Shared on November 5, 2010 at 1:40 pm By:

HealthSociety Healthy Society Health News

Anti-Delirium Drug May Harm Critically Ill Patients http://bit.ly/bNZhOv

1 year ago...

Updated NICE Guidance For Alzheimer's Disease Now Recommends The First Transdermal Patch As Well As Oral Capsules

medicalnewstoday.com — “Novartis Pharmaceuticals UK Ltd. welcomes the update to National Institute for Health and Clinical Excellence (NICE) guidance TA1111 and is pleased that the EXELON Patch (rivastigmine transdermalView full resource at medicalnewstoday.com

  • View Related
  • Share

Most Recently Shared on January 19, 2011 at 1:05 pm By:

mnt_alzheimers MNT Alzheimer's News Health News

Updated NICE Guidance For Alzheimer's Disease Now Recommends The First Transdermal Patch As Well As Oral Capsules http://mnt.to/3Q69

1 year ago...

The Top 3 resources shared on this topic. More resources.

Key stats and trends about this topic

Related Health Centers

Featuring the top 3 experts for this topic

Advertisement

Share via Email

Share this WisdomCard with others by embedding on your site or blog.

300x260

425x300

560x390